Latest filing published 21 Feb 2007 for JUNIPER PHARMACEUTICALS INC, €154k.
Insider track record
No signal scores available.
John P. Curran: trading record in brief
John P. Curran is a declared insider of Juniper Pharmaceuticals Inc, with filings sourced from SEC (Form 4). We count 2 filings; the first trade dates from 15 February 2007 and the latest from 16 February 2007.
No open-market purchase appears, only 2 sales worth €346k.
The newest entry dates from 21 February 2007: an open-market sale of €154k, in Juniper Pharmaceuticals Inc. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to John P. Curran
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 144,509 shares@ US$1.40Common StockSEC:0000919574-07-001481:0
- 178,991 shares@ US$1.41Common StockSEC:0000919574-07-001481:1
2 of 2 declarations